Faron Pharmaceuticals Oy (FARN.L)
GBp 175.0
(2.94%)
GBp 175.0
(2.94%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -449.84 EUR | 9.98% |
| 2022 | -499.69 EUR | -22.21% |
| 2021 | -408.89 EUR | -13.02% |
| 2020 | -361.78 EUR | -8.79% |
| 2019 | -332.54 EUR | 46.96% |
| 2018 | -626.96 EUR | 11.4% |
| 2017 | -707.66 EUR | -99.29% |
| 2016 | -355.09 EUR | -37.16% |
| 2015 | -258.89 EUR | -200.62% |
| 2014 | -86.12 EUR | -32.0% |
| 2013 | -65.24 EUR | 38.7% |
| 2012 | -106.42 EUR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.10 EUR | 0.0% |
| 2024 Q1 | -0.10 EUR | 23.08% |
| 2023 Q3 | -0.13 EUR | -18.18% |
| 2023 Q4 | -0.13 EUR | 0.0% |
| 2023 FY | - EUR | 18.64% |
| 2023 Q1 | -0.11 EUR | 21.43% |
| 2023 Q2 | -0.11 EUR | 0.0% |
| 2022 Q3 | -0.14 EUR | -16.67% |
| 2022 Q4 | -0.14 EUR | 0.0% |
| 2022 FY | - EUR | -40.48% |
| 2022 Q1 | -0.12 EUR | -20.0% |
| 2022 Q2 | -0.12 EUR | 0.0% |
| 2021 Q2 | -0.11 EUR | 0.0% |
| 2021 Q4 | -0.10 EUR | 0.0% |
| 2021 Q3 | -0.10 EUR | 9.09% |
| 2021 FY | - EUR | -13.51% |
| 2021 Q1 | -0.11 EUR | -10.0% |
| 2020 Q2 | -0.08 EUR | 0.0% |
| 2020 Q1 | -0.08 EUR | 4.07% |
| 2020 Q3 | -0.10 EUR | -21.36% |
| 2020 FY | - EUR | -19.35% |
| 2020 Q4 | -0.10 EUR | 0.0% |
| 2019 FY | - EUR | 52.31% |
| 2019 Q1 | -0.09 EUR | 4.82% |
| 2019 Q2 | -0.09 EUR | 0.0% |
| 2019 Q3 | -0.09 EUR | 9.39% |
| 2019 Q4 | -0.09 EUR | 0.0% |
| 2018 FY | - EUR | 14.47% |
| 2018 Q4 | -0.10 EUR | 0.0% |
| 2018 Q3 | -0.10 EUR | 56.7% |
| 2018 Q2 | -0.23 EUR | 0.0% |
| 2018 Q1 | -0.23 EUR | 8.0% |
| 2017 Q1 | -0.13 EUR | 0.0% |
| 2017 Q2 | -0.13 EUR | 0.0% |
| 2017 FY | - EUR | -94.87% |
| 2017 Q4 | -0.25 EUR | 0.0% |
| 2017 Q3 | -0.25 EUR | -92.31% |
| 2016 Q2 | -0.08 EUR | 0.0% |
| 2016 Q4 | -0.13 EUR | 0.0% |
| 2016 FY | - EUR | -44.44% |
| 2016 Q3 | -0.13 EUR | -62.5% |
| 2016 Q1 | -0.08 EUR | -5.54% |
| 2015 FY | - EUR | -357.63% |
| 2015 Q3 | -0.08 EUR | -3.55% |
| 2015 Q4 | -0.08 EUR | 0.0% |
| 2015 Q1 | -0.07 EUR | -206.28% |
| 2015 Q2 | -0.07 EUR | 0.0% |
| 2014 Q3 | -0.02 EUR | -11.16% |
| 2014 Q1 | -0.02 EUR | 0.0% |
| 2014 FY | - EUR | 9.51% |
| 2014 Q4 | -0.02 EUR | 0.0% |
| 2014 Q2 | -0.02 EUR | 0.0% |
| 2013 FY | - EUR | 40.73% |
| 2012 FY | - EUR | 0.0% |
| Name | Eps | Eps Difference |
|---|